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  Japanese Encephalitis virus (JEV) is a mosquito borne flavivirus that infects 
macrophages, monocytes and dendritic cells (DCs) during in vivo replication. The 
C-type lectins DC-SIGN and DC-SIGNR have been reported to act as cell 
attachment factors for diverse array of pathogens. In this study, the effect of these 
lectins on JEV infection was investigated after the generation of 293T-SIGN (R) 
cell lines expressing DC-SIGN and DC-SIGNR receptors. It was observed that only 
DC-SIGN but not the DC-SIGNR can act as a viral attachment factor in case of JEV 
infection. The infection to cells expressing DC-SIGN was efficiently blocked by 
anti-DC-SIGN and mannan molecules. It was also found that insect derived JEV has 
higher affinity for DC-SIGN as compare to the mammalian derived JEV. These 
results initially suggest that DC-SIGN could act as viral attachment receptors 
(VAR) for JEV and enhance JEV infection. 
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INTRODUCTION 
 
Japanese Encephalitis virus (JEV) is the most 
common cause of vaccine preventable encephalitis in Asia 
leading to 10,000 deaths every year. It is a mosquito-
borne (+) sense single stranded RNA virus belonging to 
Flaviviridae family. After the bite of an infected mosquito 
to vertebrate host, virus infects local lymph nodes and 
begins to replicate. Then it enters the blood stream 
causing viremia (Kimura et al., 2010). Peripheral blood 
mononuclear cells (PBMCs) are thought to play a central 
role in JEV pathogenesis. Different mechanisms for JEV 
interaction with DCs and macrophages have been 
described including both Myd88 dependent and 
independent pathways (Aleyas et al., 2009). These 
interfering pathways lead to immunosuppression, viral 
survival and its dissemination to other parts of the body 
(Kaisho and Akira, 2001).  
Since JEV interaction with DCs play a crucial role in 
viral dissemination and modulation of immune responses, 
it is imperative to recognize different JEV specific 
receptors/attachment factors on DCs, their viral ligands 
and contributions of these receptor-ligand interactions to 
JEV pathogenesis. Viral attachment factors are the 
nonessential cellular proteins which facilitates the virus 
binding to cell surface (Baribaud et al., 2002a). Two of 
the most comprehensively studied attachment factors 
include C-type lectins: DC-SIGN (CD209)  (Geijtenbeek 
et al., 2000) and DC-SIGNR (L-SIGN or CD209L) 
(Bashirova et al., 2001) [henceforth referred collectively 
as DC-SIGN (R)]. High level of DC-SIGN expression has 
been reported in vitro in monocyte-derived DCs 
(Geijtenbeek et al., 2000) as compare to in vivo in DCs ; 
Soilleux  et al., 2002) and macrophages (Krutzik et al., 
2005). DC-SIGNR is expressed on micro-vascular 
endothelial cells (especially in lymph nodes and liver 
sinusoids) (Bashirova et al., 2001). According to various 
reports, DC-specific C type lectin DC-SIGN is an 
important attachment factor for dissemination of several 
pathogens. As viral attachment factors, DC-SIGN (R) can 
enhance the susceptibility of permissive cells to viral 
infection or allow non-permissive cells to bind and 
transmit captured pathogens to target cells in trans 
(Halary  et al., 2002; 
  Navarro-Sanchez  et al., 2003; 
Mesman et al., 2012; Zhang et al., 2012; Borggren et al., 
2013). These attachment factors have high affinity for the 
mannose containing carbohydrates on viral glycoproteins 
(Klimstra  et al., 2003; Lin et al., 2003; Johnson et al 
2011; Alen et al., 2012). Several studies have 
demonstrated the interaction of other flaviviruses with 
DCs via DC-SIGN (R) attachment factors. 
In this study, the role of DC-SIGN (R) in JEV 
pathogenesis was investigated. It was observed that DC-
SIGN can efficiently enhance the susceptibility of 
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permissive cells to JEV infection, whereas DC-SIGNR 
was not found to be as an important attachment factor in 
case of JEV infection.  
 
MATERIALS AND METHODS 
 
Cells, viruses and antibodies: Human embryonic kidney 
293T cells and baby hamster kidney cells (BHK-21) were 
grown at 37
°C  and maintained in Dulbecco’s Modiﬁed 
Eagle’s Medium (DMEM, Sigma–Aldrich, MO, USA) 
supplemented with 10% fetal bovine serum (FBS, Gibco). 
C6/36 cells were grown at 28
°C  and maintained in 
Modiﬁed Eagle’s Medium (MEM, Sigma-Aldrich, MO, 
USA) supplemented with 10% FBS. 
For generation of cell lines expressing DC-SIGN (R), 
full-length coding sequences of DC-SIGN (R) were 
cloned into pcDNA3.1. The constructs and vector were 
transfected into 293T cells. The expression of DC-SIGN 
and DC-SIGNR on cell surface was detected by the 
Indirect immunofluorescence assay (IFA) and western 
bolt. The 293T cells expressing DC-SIGN and DC-
SIGNR henceforth will be referred as 293T-SIGN and 
293T-SIGNR respectively and 293T-SIGN (R) 
collectively. 
 JEV wild type strain P3 was propagated in BHK-21 
and C6/36 cells. Viral titers were determined by viral 
plaque assay on BHK cells as described by Wu et al. 
(2011). The anti-DC-SIGN and anti-DC-SIGNR 
antibodies from R & D system were used in this study.  
The anti-JEV polyclonal antibodies were generated in our 
laboratory. The Alexa Fluor
® 555-labelled secondary anti-
rabbit IgG and Alexa Fluor 
® 488-labelled secondary anti-
mouse IgG were purchased from Invitrogen.   
 
IFA, blocking Assay and real-time PCR: Cultured cells 
were fixed in 4% paraformaldehyde and nonspecific 
binding sites were blocked with PBS containing BSA. 
Cells were then incubated with appropriate primary 
antibodies followed by florescence conjugated secondary 
antibodies. Nuclei were stained with DAPI (4', 6-
diamidino-2-phenylindole) and analyzed using confocal 
microscope.  
Triplicate wells of 293T cell lines expressing DC-
SIGN(R) were treated with 4mg/ml of mannan (Sigma) or 
40µg/ml of anti-DC-SIGN(R) mAb, at 37°C for 1h prior 
to infection with viruses. qRT-PCR experiments were 
carried out by the Primer Script RT reagent Kit (TaKaRa) 
and SYBR Green Real time PCR Master Mix (TaKaRa) 
according to the manufacturer’s instructions. The forward 
and reverse gene-speciﬁc primers of JEV C gene are FP: 
GGCTCATATCACGTTCTTCAAGTTTT and RP: 
TGCTTTCCATCGGCCYAAA. 
 
Statistical analysis: Statistics were calculated using 
GraphPad Prism (version 5.01; GraphPad Software, Inc.). 
A value of P<0.05 was considered statistically significant. 
 
RESULTS 
 
Expression of DC-SIGN greatly enhances the 
susceptibility of 293T cells to infection by JEV: To 
determine whether JEV binding to cells can be influenced 
by cell surface expression of DC-SIGN (R), 293T-SIGN 
(R) cells were infected with JEV. The confocal 
microscopic analysis revealed that JEV protein can co-
localize with 293T-SIGN and 293T-SIGNR cells 
throughout the cell surface. 48 hours post infection, 
confocal analysis revealed the increased internalization of 
JEV to 293T-SIGN cells as compare to 293T-SIGNR and 
control (Fig. 1). 
In order to further investigate the interaction between 
DC-SIGN(R) and JEV, 293T-SIGN and 293T-SIGNR 
cells were infected with serial dilutions of JEV. In 
agreement with the previous findings, significantly 
enhanced level (P<0.05) of JEV was found in 293T-SIGN 
cells as compare to the control. This increase in the 
magnitude of virus production was found to be more than 
10-fold at 0.0001 MOI in 293T-SIGN cells. Whereas in 
contrast to the previous findings with West Nile virus 
(WNV) and Dengue virus (Tassaneetrithep et al., 2003;
 
Davis  et al., 2006) the level of JEV in 293T-SIGNR 
infected cells was not found to be significant as compare 
to control (Fig. 2). Results of this experiment revealed a 
dose dependent increase in viral replication in 293T-SIGN 
cells. To further validate the results qRT-PCR was 
performed. Supporting the viral plaque assay results, the 
data of qRT-PCR also showed increased viral replication 
in 293T-SIGN cells, demonstrated by increased copies of 
virus C gene (P<0.05) at each time point. From these 
experiments it can be concluded that the expression of 
DC-SIGN can increase the viral infectivity in a dose 
dependent manner.  
 
JEV derived from mosquito and mammalian cell lines 
do not confer a similar infection:  It has already been 
demonstrated in case of WNV and Sindbis virus that 
C6/36 mosquito cell line derived virus can interact with 
DC-SIGN  (R)  in   a   more   efficient   manner   and   this 
increased affinity is the result of incorporation of high-
mannose glycans (Klimstra et al., 2003; Davis et al., 
2006). Since JEV is a mosquito-borne pathogen so it was 
examined whether JEV from C6/36 and BHK-21 derived 
cells could behave differently in their interactions with C-
type lectins. After infecting the 293T-SIGN (R) cells with 
JEV (MOI=0.01), qRT-PCR was performed at different 
time points (24s, 48 h and 72 h). Interestingly C6/36 
derived JEV produced more viral C gene at 24 and 48 hpi 
(P<0.01) but after 72 hpi C gene level was found to be 
same in mammalian and mosquito derived cell lines (Fig. 
3A & B). It was supposed due to the internal equilibrium 
status (saturation) achieved. In addition to qRT-PCR, viral 
plaque assay was also performed at 72 hpi which revealed 
significantly increased viral production from C6/36 
derived JEV (Fig. 3C). So these results are in complete 
harmony with the previous findings regarding other 
flaviviruses that mosquito derived virus can interact with 
DC-SIGN more efficiently. But interestingly this study 
demonstrate an increased affinity of insect derived virus for 
DC-SIGN not for DC-SIGNR, a reverse of this has already 
been reported in case of WNV (Davis et al., 2006). 
 
Speciﬁc inhibitors block DC-SIGN mediated increased 
susceptibility of the 293T-SIGN cells:  To substantiate 
that DC-SIGN is indeed involved in increased 
susceptibility of cells to JEV, inhibitors of DC-SIGN were 
used to block JEV infection on 293 T-SIGN cells. ThePak Vet J, 2013, 33(4): 408-412. 
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Fig. 1: Colocalization of DC-SIGN(R) and JEV proteins. 293T cells expressing DC-SIGN(R) were infected with JEV. Lectins expression were detected 
by MAb161 (anti-DC-SIGN) and MAb162 (anti-DC-SIGNR) (green). JEV proteins were detected by anti-JEV polyclonal antibody (red).Confocal 
images show that DC-SIGN(R) proteins distributed throughout the cell surface and cytoplasm. Co-localization of DC-SIGN and JEV was evidenced by 
merged images (yellow). 
 
results showed that both mannan and anti-DC-SIGN can 
effectively block DC-SIGN mediated enhancement of 
JEV infection as demonstrated by viral plaque assay. 
Mannan and anti-DC-SIGN mAb reduce viral levels 91 
folds (P=0.0006) and 21 folds (P=0.0007) lower than of 
untreated groups respectively. No significant difference 
was found between mannan and anti-DC-SIGN mAb in 
their abilities to block the infection. To further investigate 
the role of DC-SIGNR, a blocking assay with 293T-SIGNR 
cells was performed. The viral plaque assay suggested that 
293T-SIGNR cells pre-incubated with blocking agents has 
no effect on JEV infection (Fig. 4A & B).  
 
DISCUSSION 
 
C-type lectins such as DC-SIGN and DC-SIGNR, 
which bind mannose rich carbohydrate modifications of 
pathogen proteins, have been shown to facilitate viral 
infection either cis or trans  (Klimstra  et al., 2003). 
Several early targets of arbovirus infection (dendritic cells 
and cells of reticuloendothelial system) express DC-SING 
(R) receptors (Klimstra et al., 2003), making them 
important to understand how these lectins interact with 
JEV. Interestingly in this study it was found that JEV 
interacts efficiently with DC-SIGN whereas no significant 
interaction difference was observed between 293T-
SIGNR and controls. The preferential binding of DC-
SIGN by any other flavivirus has not previously been 
observed although Davis et al. (2006), has described the 
preferential binding of WNV to DC-SIGNR. In agreement 
with previous findings for other viruses, it was also 
observed that JEV derived from mosquito cell line 
interacts more efficiently with DC-SIGN as compare to 
mammalian cell line derived virus. It is likely that the 
interaction of mammalian and insect cell derived JEV 
carbohydrates with DC-SIGN is of much higher affinity 
than that of DC-SIGNR.    
The C-type lectin family of attachment factors/ 
receptors has biologically diverse functions. High 
expression level of DC-SIGN has been demonstrated on 
immature DCs and macrophage subpopulations abundant 
in the dermis of skin, peripheral tissues, at mucosal 
surfaces and in lymph nodes (Soilleux et al., 2002; van 
Kooyk  et   al.,  2013).   DCs   and   macrophages   act   as Pak Vet J, 2013, 33(4): 408-412. 
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Fig. 2: DC-SIGN enhances the propagation of JEV in 293T cells. 293T 
cells were infected with JEV at MOI of 0.01, 0.001 and 0.0001, 
respectively. Titer of JEV in the media was determined by viral plaque 
assays on BHK cell monolayers. Data are expressed as mean and SD of 
triplicate wells. Representative data from two independent experiments 
are shown. 
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Fig. 3: C6/36 derived JEV demonstrates increased affinity for DC-SIGN 
as compare to DC-SIGNR. Cells were infected with C6/36 or BHK 
derived JEV at MOI of 0.01. JEV C gene replication kinetics was 
determined by qRT-PCR (A & B). Viral titers in the media were 
determined at 72hpi in BHK cells (C). Data are expressed as mean and 
SD of triplicate wells. Representative data from two independent 
experiments are shown. 
 
 
 
 
Fig. 4: Speciﬁc inhibitors block JEV infection in 293T-SIGN cells. 293T 
cells expressing DC-SIGN(R) were either treated with mannan or mAb 
(anti-DC-SIGN or anti-DC-SIGNR) at 37 for 1h prior to infection with 
virus [C6/36 cell derived virus (A) or mammalian derived virus (B)] at a 
MOI of 0.01. Virus titer was determined by viral plaque assays on BHK 
cell monolayers. Data are expressed as mean and SD of triplicate wells. 
Representative data from two independent experiments are shown. 
 
professional antigen presenting cells, any invading 
pathogen is sensed, engulfed, processed and antigens are 
presented. Several studies have confirmed DC-SIGN (R) 
as important receptor for many pathogens. HIV
  (Boily-
Larouche et al., 2012), Ebola virus, Cytomegalovirus 
(Baribaud et al., 2002b), Dengue virus (Tassaneetrithep et 
al., 2003), and WNV (Davis et al., 2006) have been 
shown to gain entry into DCs by utilizing these receptors. 
In this study it was demonstrated that DC-SIGN not only 
confers binding to 293T cells but also enhance 293Tcells 
susceptibility to JEV infection. This enhanced 
susceptibility to infection was found to be in a dose 
dependent manner which has previously been proved in 
case of Dengue virus (Tassaneetrithep et al., 2003) so 
very low MOIs are sufficient for enhanced infection, 
replication and production of JEV in DC-SIGN expressing 
cells. But it is still remains to be determined whether DC-
SIGN can promote spreading of infection as it has been 
documented in case of Dengue virus (Tassaneetrithep et 
al., 2003). Interestingly JEV virus can discriminate 
between DC-SIGN and DC-SIGNR receptors but it is 
worth mentioning that JEV only utilizes DC-SIGN and no 
interaction with DC-SIGNR was found. Inhibitors 
blocking assay further proved that the increased 
susceptibility observed in this study is indeed due to the 
DC-SIGN expression. Although this is a preliminary 
study conducted on 293T cells but as it has already been Pak Vet J, 2013, 33(4): 408-412. 
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reported by Davis et al. (2006), that expression of DC-
SIGN (R) on 293T cells was indeed yielded same results 
for SupT1, BHK, CHO-K1, and Primary cell types. So in 
authors opinion the results will not differ much in case of 
primary cell types but the need of study to be conducted 
on the primary cell types cannot be negated.   
In this study, the role of DC-SIGN (R) in case of JEV 
pathogenesis was investigated which revealed that DC-
SIGN but not the DC-SIGNR is an important VAR. It was 
also observed that insect derived JEV has higher affinity 
for DC-SIGN as compare to mammalian derived virus. 
This preferential utilization of DC-SIGN by JEV needs to 
be explored in depth to further reveal the differences 
between the other closely related flavivirus like WNV 
which preferentially bind to DC-SIGNR. These results 
should be considered the first report of DC-SIGN acting 
as a pathogen recognition receptor of JEV and also that 
JEV can discriminate between DC-SIGN and DC-SIGNR 
attachment factors. It will be of great interest to 
investigate the viral glycoproteins that contribute in this 
discrimination. Furthermore, the findings regarding 
utilization of DC-SIGN by JEV can further serve to probe 
the pathogenesis of JEV infection. These findings are 
significant addition in the existing pool of literature 
regarding JEV utilization of receptors and entry pathways.   
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